NXL
Nexalin Technology Inc.
NASDAQ: NXL · HEALTHCARE · MEDICAL DEVICES
$0.36
+2.42% today
Updated 2026-04-30
Market cap
$8.34M
P/E ratio
—
P/S ratio
27.63x
EPS (TTM)
$-0.50
Dividend yield
—
52W range
$0 – $2
Volume
0.6M
Nexalin Technology Inc. (NXL) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | $-678336.00 | $-863474.00 | $-1.08M | $-2.22M | $-3.84M | $-3.94M | $-4.96M |
| Capital expenditures | $4.00 | $648.00 | $0.00 | $0.00 | $109279.00 | $170306.00 | $96859.00 |
| Depreciation | — | — | — | — | — | — | — |
| Stock-based comp | $562735.00 | $1.96M | $4.48M | $270670.00 | $2.41M | $3.56M | $3.12M |
| Free cash flow | $-678340.00 | $-864122.00 | $-1.08M | $-2.22M | $-3.94M | $-4.11M | $-5.05M |
| Investing cash flow | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — |